A PHASE 1B STUDY OF THE COMBINATION OF VADASTUXIMAB TALIRINE AND 7+3 INDUCTION THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Levy, MY; Stein, AS; Vasu, S; Maris, MB; Advani, AS; Fathi, AT; Faderl, S; Walter, RB; Smith, SE; Yang, J; Donnellan, WB; Wood, BL; Ravandi, F; Feldman, EJ; Voellinger, JL; Erba, H

Published Date

  • June 26, 2017

Published In

Volume / Issue

  • 102 /

Start / End Page

  • 324 - 324

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 22nd Congress of the European-Hematology-Association

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • June 22, 2017

Conference End Date

  • June 25, 2017